PRODUCT

Healthcare Intelligence is an application within Thomson Reuters Eikon™, which integrates detailed drug pipeline information from TR Cortellis™ into an intuitive and powerful research tool for financial analysts in the biotech and pharmaceutical sectors.

Design Highlights

  • Incremental search function with auto-suggestions

  • Dashboard with curated content and data visualization

  • Rich data flows with multiple filtering design components

  • Share, save and download actions to take data outside the software

 
 
“Your app achieves in seconds what currently takes me weeks.”
— Dave C., research analyst

The Challenge

Thomson Reuters Eikon is a comprehensive source of financial data but is limited in health-related data. In October 2015, research revealed an unmet need from a specific type of Thomson Reuters Eikon™ customer: Eikon’s healthcare financial analysts want an easy way to search for companies active in specific drugs, analyze drug historical and forecasted revenues, and access detailed reports about drugs and companies.

Background Research

No healthcare database on the market offers a consistent way to search by indication (ie. asthma, cancer).

Healthcare-focused financial users work with specific types of data that help them understand the competitive landscape for a particular disease: the main players, drugs, companies, funding, and patents. Their goal is to advise their company on buying or selling healthcare technology, acquiring a startup, divesting a company, etc. However, their day-today workflow, which includes using Eikon and Cortellis, has them collecting and curating drug pipeline information from as many as eight databases!

Hypothesis

We believed that integrating data from Cortellis, Thomson Reuters’ database for life science professionals, into Eikon, would help fulfill our target users’ need for an efficient way to analyze the healthcare industry. Cortellis provides a very comprehensive range of healthcare data, within a simple and intelligent UI and flow inside Eikon.

Target Users

Healthcare financial analysts, including:

  • Healthcare coverage investment bankers

  • Buy side equity analysts

  • Sell side research analysts

Immediate Impact on Sales Revenue

In the first 4 months of launch, the solution played a crucial role in signing $1.8M in annual revenues from 12 new Eikon sales and the migration of 350+ users from legacy offerings onto Eikon. Within one year, the app had 450 Eikon new users, including 250 repeats!